Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Non-Interventional Cohort Study to Evaluate the Real-World Clinical Management and Outcomes of Patients Diagnosed With ALK-Positive Advanced NSCLC Treated With Alectinib (ReAlec)

NCT04764188 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT04764188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04764188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Non-Interventional Cohort Study to Evaluate the Real-World Clinical Management and Outcomes of Patients Diagnosed With ALK-Positive Advanced NSCLC Treated With Alectinib (ReAlec)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Active, not recruiting
Start date
May 10, 2021
Completion date
May 10, 2027
Enrollment
800 (estimated)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc